Onconetix, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Onconetix, Inc. (ONCO) reported Increase (Decrease) in Prepaid Expense and Other Assets of $15.79 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-13
- Onconetix, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$67.60K.
- Onconetix, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $83.40K.
- Onconetix, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $499.23K.
- Onconetix, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$169.49K.
- Onconetix, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $128.36K.
- Onconetix, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$1.02M, a 346.75% decline from fiscal 2023.
- Onconetix, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $412.60K, a 75.81% increase from fiscal 2022.
- Onconetix, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $234.68K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$67.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $15.79K 10-Q · filed 2026-08-13 | $515.02K derived: sum of 3 quarters · filed 2026-08-13 | $345.53K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2026-03-31 | $83.40K 10-Q · filed 2026-05-13 | $582.62K derived: sum of 2 quarters · filed 2026-05-13 | $413.13K derived: sum of 3 quarters · filed 2026-05-13 | $215.39K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-12-31 | $499.23K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $329.74K derived: sum of 2 quarters · filed 2026-03-13 | $132.00K derived: sum of 3 quarters · filed 2026-08-13 | $128.36K 10-K · filed 2026-03-13 | |||
| 2025-09-30 | -$169.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$367.23K derived: sum of 2 quarters · filed 2026-08-13 | -$370.87K 10-Q · filed 2025-11-13 | -$1.32M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-06-30 | -$197.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$201.38K 10-Q · filed 2026-08-13 | -$1.15M derived: sum of 3 quarters · filed 2026-08-13 | -$1.44M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-03-31 | -$3.64K 10-Q · filed 2026-05-13 | -$951.18K derived: sum of 2 quarters · filed 2026-05-13 | -$1.24M derived: sum of 3 quarters · filed 2026-05-13 | -$1.44M derived: sum of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | -$947.55K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$1.24M derived: sum of 2 quarters · filed 2026-03-13 | -$1.44M derived: sum of 3 quarters · filed 2026-03-13 | -$1.02M 10-K · filed 2026-03-13 | |||
| 2024-09-30 | -$291.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$490.09K derived: sum of 2 quarters · filed 2025-11-13 | -$70.56K 10-Q · filed 2025-11-13 | $7.75K 10-Q · filed 2024-12-10 | $325.16K derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | -$198.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $220.93K 10-Q · filed 2025-08-14 | $7.75K 10-Q · filed 2024-08-29 | $616.65K derived: sum of 3 quarters · filed 2025-08-14 | $616.65K derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | $419.53K 10-Q · filed 2025-06-12 | $815.25K derived: sum of 2 quarters · filed 2025-06-12 | $815.25K derived: sum of 3 quarters · filed 2025-06-12 | $510.17K derived: sum of 4 quarters · filed 2025-06-12 | |||
| 2023-12-31 | $395.72K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-02 | $395.72K derived: sum of 2 quarters · filed 2025-06-02 | $90.64K derived: sum of 3 quarters · filed 2025-06-02 | $412.60K 10-K · filed 2025-06-02 | |||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-12-10 | -$305.08K derived: sum of 2 quarters · filed 2024-12-10 | $16.88K 10-Q · filed 2024-12-10 | $9.53K 10-Q · filed 2023-11-17 | -$217.72K derived: sum of 4 quarters · filed 2024-12-10 | ||
| 2023-06-30 | -$305.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-29 | $16.88K 10-Q · filed 2024-08-29 | $227.20K 10-Q · filed 2023-10-20 | -$217.72K derived: sum of 3 quarters · filed 2024-08-29 | -$526.89K derived: sum of 4 quarters · filed 2024-08-29 | ||
| 2023-03-31 | $321.96K 10-Q · filed 2024-05-20 | $87.36K derived: sum of 2 quarters · filed 2024-05-20 | -$221.81K derived: sum of 3 quarters · filed 2024-05-20 | $701.19K derived: sum of 4 quarters · filed 2024-05-20 | |||
| 2022-12-31 | -$234.60K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-11 | -$543.77K derived: sum of 2 quarters · filed 2024-04-11 | $379.23K derived: sum of 3 quarters · filed 2024-04-11 | $234.68K 10-K · filed 2024-04-11 | |||
| 2022-09-30 | -$309.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-17 | $613.82K derived: sum of 2 quarters · filed 2023-11-17 | $469.28K 10-Q · filed 2023-11-17 | $66.36K 10-Q · filed 2022-11-14 | $599.68K derived: sum of 4 quarters · filed 2023-11-17 | ||
| 2022-06-30 | $923.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-10-20 | $778.45K 10-Q · filed 2023-10-20 | $73.97K 10-Q · filed 2022-08-15 | $908.85K derived: sum of 3 quarters · filed 2023-10-20 | $862.62K derived: sum of 4 quarters · filed 2023-10-20 | ||
| 2022-03-31 | -$144.55K 10-Q · filed 2023-05-12 | $129.45K 10-Q · filed 2022-05-13 | -$14.15K derived: sum of 2 quarters · filed 2023-05-12 | -$60.38K derived: sum of 3 quarters · filed 2023-05-12 | -$106.61K derived: sum of 4 quarters · filed 2023-05-12 | ||
| 2021-12-31 | $130.40K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $84.17K derived: sum of 2 quarters · filed 2023-03-09 | $37.93K derived: sum of 3 quarters · filed 2023-03-09 | -$8.30K 10-K · filed 2023-03-09 | |||
| 2021-09-30 | -$46.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$92.47K derived: sum of 2 quarters · filed 2022-11-14 | -$138.70K 10-Q · filed 2022-11-14 | ||||
| 2021-06-30 | -$46.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$92.47K 10-Q · filed 2022-08-15 | |||||
| 2021-03-31 | -$46.23K 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |